IMMUNOSENS Co. Ltd. announced that it has received a round of funding on July 26, 2023. The transaction included participation from new investor, Shimadzu Future Innovation Fund L.P., a fund co-managed by Global Brain Co., Ltd., and Shimadzu Corporation.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4,223 JPY | +1.10% | +2.90% | +7.13% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.13% | 7.91B | |
-3.15% | 4.66B | |
-9.18% | 2.84B | |
+1.11% | 2.03B | |
-26.56% | 1.12B | |
-22.71% | 759M | |
-13.49% | 755M | |
-56.85% | 682M | |
-24.66% | 671M | |
-29.38% | 632M |
- Stock Market
- Equities
- 7701 Stock
- News Shimadzu Corporation
- IMMUNOSENS Co. Ltd. announced that it has received funding from Global Brain Co., Ltd., Shimadzu Corporation